Under
Embargo Till: 18:00 UTC Sept. 20, 2007
Posted:
18:00 UTC 09/20/2007
Genome
Of Parasitic Worm Cracked By Scientists
Thursday, September 20, 2007
Brugia
malayi
Filarial
worms infect over 130 million people worldwide
The DNA of a parasitic worm
that causes the painful and disfiguring disease elephantiasis has
been successfully sequenced by scientists. The data, published
today (20 September) in Science, provides researchers with a
genetic 'blueprint' of the filarial worm Brugia malayi.
Scientists hope this will lead to the identification of new genes
to target with drugs, and eventually to the development of a
vaccine to prevent infection.
Filarial worms infect over 130
million people worldwide with an additional 1.1 billion believed
to be at risk of infection, mostly in Africa and Asia. The
parasites are transmitted by a mosquito bite and once inside the
human body develop into adult worms in the lymphatic vessels,
causing severe damage, pain and swelling. Elephantiasis -
painful, disfiguring swelling of the legs and genital organs - is
a classic sign of late-stage disease.
The new research, carried out
by scientists in the UK and the USA, involved identifying all the
genes encoded in the worm's DNA. Identifying the genes means
researchers can then work out what proteins this particular
species is able to produce, leading to an understanding of issues
such as how the worm's metabolism works, or how it manages to
infect a human host.
One of the authors, Dr David B.
Guiliano from Imperial College London's Department of Life
Sciences, explains: "Proteins are essential parts of all
organisms, and participate in every process within cells.
Scientists can now conduct detailed analyses of the information
in the genetic code of this worm to see what proteins it
produces, thereby giving a clearer insight than ever before into
this parasite's biology.
"We hope that our data
will enable both ourselves and other research teams around the
world to move forward and study the mechanisms by which this
parasite infects humans in greater detail, which should lead to
better targeted drugs to treat infection, and hopefully - in the
long run - a vaccine to prevent it."
The study was led by Elodie
Ghedin at the Institute for Genome Research, the J. Craig Venter
Institute and the University of Pittsburgh in the USA and funded
by the National Institutes of Health (NIH).
Source:
Imperial College London

|
Scientific
Frontline®
The
Comm Center
Space
Weather Alerts
Stellar
Nights®
The
E.A.R.®
World
Report News
Photo,
Sketches, & Video Gallery
|